Canalija, Gabrielle Asher .
HRN: 23-66-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/10/2023
10/17/2023
IVT
18mg
OD
Hyperbilorubinemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes